Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04199793 · ClinicalTrials.gov registry record · NA
Lavare Cycle in Patients Receiving HeartWare Left Ventricular Assist Device
A NA study, sponsored by Vanderbilt University Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT04199793 is a NA study that was terminated before completion, run by Vanderbilt University Medical Center. The registered enrollment target is 9 participants.
The verdict
NCT04199793, a NA study, was terminated before completion, sponsored by Vanderbilt University Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
Left ventricular assist device (LVAD) patients remain at risk for pump thrombus and thromboembolic events through multiple mechanisms. The HeartWare® Ventricular Assist System (HVAD®, HeartWare Inc., Framingham, MA, USA) includes a novel speed modulation feature called Lavare™ cycle. The Lavare™ Cycle is aimed to promote washing of left ventricle to decrease blood stasis and subsequent risk of thrombus formation, ingestion and/or expulsion. No prior study has prospectively evaluated the impact of Lavare™ cycle on patient outcomes in a randomized fashion. We intend to assess effects of Lavare™ Cycle among patients receiving HVAD LVAD in this randomized controlled pilot project.
Interventions
- DEVICE Lavare On
- DEVICE Lavare Off
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2020-08-10 |
| Est. Completion | 2021-08-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04199793
The ClinicalTrials.gov registry entry for NCT04199793 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lavare On is the first listed.
NCT04199793 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04199793 about?
NCT04199793 is a clinical study titled "Lavare Cycle in Patients Receiving HeartWare Left Ventricular Assist Device". Left ventricular assist device (LVAD) patients remain at risk for pump thrombus and thromboembolic events through multiple mechanisms. The HeartWare® Ventricular Assist System (HVAD®, HeartWare Inc., Framingham, MA, USA) includes a novel speed modulation feature called Lavare™ cycle. The Lavare™ Cyc...
What is the current status of trial NCT04199793?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2020-08-10. Estimated completion is 2021-08-10.
What interventions are being tested in trial NCT04199793?
The interventions under investigation include: Lavare On (DEVICE), Lavare Off (DEVICE).
Who is sponsoring clinical trial NCT04199793?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.